Genzyme Drug Helps Patients Who Need Stem Cell Transplant
A new drug, recently approved by the Food and Drug Administration, is stimulating stem cell growth for some cancer patients who need a life-saving stem cell transplant. As NewsCenter 5’s Heather Unruh reported Thursday, the drug, developed by Genzyme, is changing the way doctors treat patients.
[Read the full article here]Related News:
Tarix Pharma stem cell transplant drug wins orphan drug status
Genzyme Gets Positive Opinion For Stem Cell Mobilization Drug Mozobil …
Genzyme's Mozobil gets nod for Europe approval